{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:59:02Z","timestamp":1785326342400,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178315"],"award-info":[{"award-number":["PJT-178315"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008914","name":"Ontario Brain Institute","doi-asserted-by":"publisher","award":["IDS11-02"],"award-info":[{"award-number":["IDS11-02"]}],"id":[{"id":"10.13039\/100008914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["887172"],"award-info":[{"award-number":["887172"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"DOI":"10.1038\/s41431-026-02199-3","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:01:17Z","timestamp":1785322877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing ARID1B-related disorders and variants of uncertain significance using DNA methylation"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2033-5040","authenticated-orcid":false,"given":"Anthony","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9516-1797","authenticated-orcid":false,"given":"Manav","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Baribeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6552-402X","authenticated-orcid":false,"given":"William T.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Deardorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-341X","authenticated-orcid":false,"given":"Fowzan S.","family":"Alkuraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Dario","family":"Ortigoza-Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8326-1999","authenticated-orcid":false,"given":"Stephen W.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa","family":"Choufani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6501-4150","authenticated-orcid":false,"given":"Rosanna","family":"Weksberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2199_CR1","doi-asserted-by":"publisher","unstructured":"Choufani S, Cytrynbaum C, Chung BHY, Turinsky AL, Grafodatskaya D, Chen YA, et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat Commun. 2015. https:\/\/doi.org\/10.1038\/ncomms10207.","DOI":"10.1038\/ncomms10207"},{"key":"2199_CR2","doi-asserted-by":"publisher","unstructured":"Rots D, Chater-Diehl E, Dingemans AJM, Goodman SJ, Siu MT, Cytrynbaum C, et al. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature. Am J Hum Genet. 2021. https:\/\/doi.org\/10.1016\/j.ajhg.2021.04.008.","DOI":"10.1016\/j.ajhg.2021.04.008"},{"key":"2199_CR3","doi-asserted-by":"publisher","unstructured":"Butcher DT, Cytrynbaum C, Turinsky AL, Siu MT, Inbar-Feigenberg M, Mendoza-Londono R, et al. CHARGE and Kabuki Syndromes: gene-specific DNA methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions. Am J Hum Genet. 2017. https:\/\/doi.org\/10.1016\/j.ajhg.2017.04.004.","DOI":"10.1016\/j.ajhg.2017.04.004"},{"key":"2199_CR4","doi-asserted-by":"publisher","unstructured":"Choufani S, Gibson WT, Turinsky AL, Chung BHY, Wang T, Garg K, et al. DNA methylation signature for EZH2 functionally classifies sequence variants in three PRC2 complex genes. Am J Hum Genet. 2020; https:\/\/doi.org\/10.1016\/j.ajhg.2020.03.008.","DOI":"10.1016\/j.ajhg.2020.03.008"},{"key":"2199_CR5","doi-asserted-by":"publisher","unstructured":"Janssen SM, Lorincz MC. Interplay between chromatin marks in development and disease. Nat Rev Genet. 2022. https:\/\/doi.org\/10.1038\/s41576-021-00416-x.","DOI":"10.1038\/s41576-021-00416-x"},{"key":"2199_CR6","doi-asserted-by":"publisher","unstructured":"Aref-Eshghi E, Kerkhof J, Pedro VP, France GDI, Barat-Houari M, Ruiz-Pallares N, et al. Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. Am J Hum Genet. 2020. https:\/\/doi.org\/10.1016\/j.ajhg.2020.01.019.","DOI":"10.1016\/j.ajhg.2020.01.019"},{"key":"2199_CR7","doi-asserted-by":"publisher","unstructured":"Chater-Diehl E, Ejaz R, Cytrynbaum C, Siu MT, Turinsky A, Choufani S, et al. New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome. BMC Med Genomics. 2019. https:\/\/doi.org\/10.1186\/s12920-019-0555-y.","DOI":"10.1186\/s12920-019-0555-y"},{"key":"2199_CR8","doi-asserted-by":"publisher","unstructured":"Aref-Eshghi E, Bend EG, Hood RL, Schenkel LC, Carere DA, Chakrabarti R, et al. BAFopathies\u2019 DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin\u2013Siris and Nicolaides\u2013Baraitser syndromes. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-07193-y","DOI":"10.1038\/s41467-018-07193-y"},{"key":"2199_CR9","doi-asserted-by":"publisher","unstructured":"Alfert A, Moreno N, Kerl K. The BAF complex in development and disease. Epigenetics Chromatin. 2019. https:\/\/doi.org\/10.1186\/s13072-019-0264-y.","DOI":"10.1186\/s13072-019-0264-y"},{"key":"2199_CR10","unstructured":"Schrier Vergano S, Santen G, Wieczorek D, Matsumoto N. Coffin-Siris Syndrome. 2013. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK131811\/."},{"key":"2199_CR11","unstructured":"Abdul-Rahman O. Nicolaides-Baraitser Syndrome. 2015. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK321516\/."},{"key":"2199_CR12","doi-asserted-by":"publisher","unstructured":"Moffat JJ, Jung EM, Minhan K, Smith AL, Jeon BT, Santen GWE, et al. The role of ARID1B, a BAF chromatin remodeling complex subunit, in neural development and behavior. Prog Neuropsychopharmacol Biol Psychiatry. 2019. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.08.021.","DOI":"10.1016\/j.pnpbp.2018.08.021"},{"key":"2199_CR13","doi-asserted-by":"publisher","unstructured":"B\u00f6gershausen N, Wollnik B. Mutational landscapes and phenotypic spectrum of SWI\/SNF-related intellectual disability disorders. Front Mol Neurosci. 2018. https:\/\/doi.org\/10.3389\/fnmol.2018.00252.","DOI":"10.3389\/fnmol.2018.00252"},{"key":"2199_CR14","doi-asserted-by":"publisher","unstructured":"Hoyer J, Ekici AB, Endele S, Popp B, Zweier C, Wiesener A, et al. Haploinsufficiency of ARID1B, a member of the SWI\/SNF-A chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet. 2012. https:\/\/doi.org\/10.1016\/j.ajhg.2012.02.007.","DOI":"10.1016\/j.ajhg.2012.02.007"},{"key":"2199_CR15","doi-asserted-by":"publisher","unstructured":"Santen GWE, Aten E, Vulto-van Silfhout AT, Pottinger C, van Bon BWM, van Minderhout IJHM, et al. Coffin-Siris syndrome and the BAF complex: genotype-phenotype study in 63 patients. Hum Mutat. 2013. https:\/\/doi.org\/10.1002\/humu.22394.","DOI":"10.1002\/humu.22394"},{"key":"2199_CR16","doi-asserted-by":"publisher","unstructured":"Tsurusaki Y, Okamoto N, Ohashi H, Mizuno S, Matsumoto N, Makita Y, et al. Coffin\u2013Siris syndrome is a SWI\/SNF complex disorder. Clin Genet. 2013. https:\/\/doi.org\/10.1111\/cge.12225.","DOI":"10.1111\/cge.12225"},{"key":"2199_CR17","doi-asserted-by":"publisher","unstructured":"van der Sluijs PJ, Jansen S, Vergano SA, Adachi-Fukuda M, Alanay Y, AlKindy A, et al. The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin\u2013Siris syndrome. Genet Med Open. 2019. https:\/\/doi.org\/10.1038\/s41436-018-0330-z.","DOI":"10.1038\/s41436-018-0330-z"},{"key":"2199_CR18","doi-asserted-by":"publisher","unstructured":"Wieczorek D, B\u00f6gershausen N, Beleggia F, Steiner-Haldenst\u00e4tt S, Pohl E, Li Y, et al. A comprehensive molecular study on Coffin\u2013Siris and Nicolaides\u2013Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. Hum Mol Genet. 2013. https:\/\/doi.org\/10.1093\/hmg\/ddt366.","DOI":"10.1093\/hmg\/ddt366"},{"key":"2199_CR19","doi-asserted-by":"publisher","unstructured":"Moffat JJ, Smith AL, Jung EM, Ka M, Kim WY. Neurobiology of ARID1B haploinsufficiency related to neurodevelopmental and psychiatric disorders. Mol Psychiatry. 2021. https:\/\/doi.org\/10.1038\/s41380-021-01060-x.","DOI":"10.1038\/s41380-021-01060-x"},{"key":"2199_CR20","doi-asserted-by":"publisher","unstructured":"van der Sluijs PJ, Alders M, Dingemans AJM, Parbhoo K, van Bon BW, Dempsey JC, et al. A case series of familial ARID1B variants illustrating variable expression and suggestions to update the ACMG criteria. Genes. 2021. https:\/\/doi.org\/10.3390\/genes12081275.","DOI":"10.3390\/genes12081275"},{"key":"2199_CR21","doi-asserted-by":"publisher","unstructured":"Beaum Beaumont RN, Hawkes G, Gunning AC, Wright CF. Clustering of predicted loss-of-function variants in genes linked with monogenic disease can explain incomplete penetrance. Genome Med. 2024. https:\/\/doi.org\/10.1186\/s13073-024-01333-4.","DOI":"10.1186\/s13073-024-01333-4"},{"key":"2199_CR22","doi-asserted-by":"publisher","unstructured":"van der Sluijs PJ, Santen GWE. Predicted loss-of-function variants before Met584 in ARID1B in population cohorts likely reflect reduced penetrance and should be reported diagnostically. Genome Medicine. 2025. https:\/\/doi.org\/10.1186\/s13073-025-01545-2.","DOI":"10.1186\/s13073-025-01545-2"},{"key":"2199_CR23","doi-asserted-by":"publisher","unstructured":"Grozeva D, Carss K, Spasic-Boskovic O, Tejada M, Gecz J, Shaw M, et al. Targeted next-generation sequencing analysis of 1000 individuals with intellectual disability. Hum Mutat. 2015. https:\/\/doi.org\/10.1002\/humu.22901.","DOI":"10.1002\/humu.22901"},{"key":"2199_CR24","doi-asserted-by":"publisher","unstructured":"Mignot C, Moutard ML, Rastetter A, Boutaud L, Heide S, Billette T, et al. ARID1B mutations are the major genetic cause of corpus callosum anomalies in patients with intellectual disability. Brain. 2016. https:\/\/doi.org\/10.1093\/brain\/aww181","DOI":"10.1093\/brain\/aww181"},{"key":"2199_CR25","doi-asserted-by":"publisher","unstructured":"Yu Y, Yao R, Wang L, Fan Y, Huang X, Hirschhorn J, et al. De novo mutations in ARID1B associated with both syndromic and non-syndromic short stature. BMC Genomics. 2015. https:\/\/doi.org\/10.1186\/s12864-015-1898-1.","DOI":"10.1186\/s12864-015-1898-1"},{"key":"2199_CR26","doi-asserted-by":"publisher","unstructured":"Bosch E, G\u00fcse E, Kirchner P, Winterpacht A, Walther M, Alders M, et al. The missing link: ARID1B non-truncating variants causing Coffin-Siris syndrome due to protein aggregation. Hum Genet. 2024. https:\/\/doi.org\/10.1007\/s00439-024-02688-9.","DOI":"10.1007\/s00439-024-02688-9"},{"key":"2199_CR27","doi-asserted-by":"publisher","unstructured":"Forwood C, Ashton K, Zhu Y, Zhang F, Dias K, Standen K, et al. Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the reclassification of an ARID1B missense variant. Am J Med Genet C Semin Med Genet. 2023. https:\/\/doi.org\/10.1002\/ajmg.c.32056.","DOI":"10.1002\/ajmg.c.32056"},{"key":"2199_CR28","doi-asserted-by":"publisher","unstructured":"Mermet-Meillon F, Mercan S, Bauer-Probst B, Allard C, Blue M, Calkins K, et al. Protein destabilization underlies pathogenic missense mutations in ARID1B. Nat Struct Mol Biol. 2024. https:\/\/doi.org\/10.1038\/s41594-024-01229-2.","DOI":"10.1038\/s41594-024-01229-2"},{"key":"2199_CR29","doi-asserted-by":"publisher","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014. https:\/\/doi.org\/10.1093\/bioinformatics\/btu049.","DOI":"10.1093\/bioinformatics\/btu049"},{"key":"2199_CR30","doi-asserted-by":"publisher","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015. https:\/\/doi.org\/10.1093\/nar\/gkv007.","DOI":"10.1093\/nar\/gkv007"},{"key":"2199_CR31","doi-asserted-by":"publisher","unstructured":"Awamleh Z, Goodman S, Kallurkar P, Wu W, Lu K, Choufani S, et al. Generation of DNA methylation signatures and classification of variants in rare neurodevelopmental disorders using EpigenCentraL. Curr Protoc. 2022. https:\/\/doi.org\/10.1002\/cpz1.597.","DOI":"10.1002\/cpz1.597"},{"key":"2199_CR32","doi-asserted-by":"publisher","unstructured":"Horvath S DNA methylation age of human tissues and cell types. Genome Biol, 2013. https:\/\/doi.org\/10.1186\/gb-2013-14-10-r115.","DOI":"10.1186\/gb-2013-14-10-r115"},{"key":"2199_CR33","doi-asserted-by":"publisher","unstructured":"McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010. https:\/\/doi.org\/10.1038\/nbt.1630.","DOI":"10.1038\/nbt.1630"},{"key":"2199_CR34","doi-asserted-by":"publisher","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. Revel: An ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016.","DOI":"10.1016\/j.ajhg.2016.08.016"},{"key":"2199_CR35","doi-asserted-by":"publisher","unstructured":"Cheng J, Novati G, Pan J, Bycroft C, \u017demgulyt\u0117 A, Applebaum T, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023. https:\/\/doi.org\/10.1126\/science.adg7492.","DOI":"10.1126\/science.adg7492"},{"key":"2199_CR36","doi-asserted-by":"publisher","unstructured":"Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet. 2022. https:\/\/doi.org\/10.1016\/j.ajhg.2022.10.013.","DOI":"10.1016\/j.ajhg.2022.10.013"},{"key":"2199_CR37","doi-asserted-by":"publisher","unstructured":"Siu MT, Butcher DT, Turinsky AL, Cytrynbaum C, Stavropoulos DJ, Walker S, et al. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants. Clin Epigenetics. 2019. https:\/\/doi.org\/10.1186\/s13148-019-0684-3.","DOI":"10.1186\/s13148-019-0684-3"},{"key":"2199_CR38","doi-asserted-by":"publisher","unstructured":"Luo X, Li M, Huang L, Nho K, Deng M, Chen Q, et al. The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors. PLoS One. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0050375.","DOI":"10.1371\/journal.pone.0050375"},{"key":"2199_CR39","doi-asserted-by":"publisher","unstructured":"Diaz-Horta O, Subasioglu-Uzak A, Grati M, DeSmidt A, Foster JII, Cao L, et al. FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing. Proc Natl Acad Sci USA. 2014. https:\/\/doi.org\/10.1073\/pnas.1401950111.","DOI":"10.1073\/pnas.1401950111"},{"key":"2199_CR40","doi-asserted-by":"publisher","unstructured":"Johnston JJ, Lewis KL, Ng D, Singh LN, Wynter J, Brewer C, et al. Individualized iterative phenotyping for genome-wide analysis of loss-of-function mutations. Am J Hum Genet. 2015. https:\/\/doi.org\/10.1016\/j.ajhg.2015.04.013.","DOI":"10.1016\/j.ajhg.2015.04.013"},{"key":"2199_CR41","doi-asserted-by":"publisher","unstructured":"Machol K, Rousseau J, Ehresmann S, Garcia T, Nguyen TTM, Spillmann RC, et al. Expanding the spectrum of BAF-related disorders: de novo variants in SMARCC2 Cause a syndrome with intellectual disability and developmental delay. Am J Hum Genet. 2019. https:\/\/doi.org\/10.1016\/j.ajhg.2018.11.007.","DOI":"10.1016\/j.ajhg.2018.11.007"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02199-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02199-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02199-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:01:29Z","timestamp":1785322889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02199-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":41,"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02199-3","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.W. is a consultant for Alamya Health.\u00a0All other\u00a0authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all research participants and\/or their guardian(s) according to the protocol approved by the Research Ethics Board of the Hospital for Sick Children (REB# 1000038847).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}